v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended 18 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Jun. 30, 2026
Cash flows from operating activities:                
Net loss $ (2,822,371) $ (3,402,264) $ (6,720,573) $ (3,063,997) $ (6,224,635) $ (9,784,570)    
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation expense         1,000 1,000    
Amortization of intangible assets         907,693    
Change in fair value of warrant liability         (10,914) (722,108)    
Change in fair value of derivative liability   662,916   59,594    
Loss on conversion of note payable     96,646    
Loss on disposition of subsidiaries   385,528   385,528    
Stock-based compensation         205,777 162,874    
Common stock issued for services         3,781,253    
Amortization of debt discount         96,935 994,640    
Amortization of right-of-use assets         20,892 29,481    
Interest income (93,750)       (187,500) (62,500)    
Changes in operating assets and liabilities:                
Accounts receivable, net         346,015 19,251    
Prepaid expenses and deposits         (163,092) (282,088)    
Inventory         10,334    
Deferred offering costs         47,384 (80,469)    
Lease liability         (21,591) (30,514)    
Accounts payable         (526,495) (45,084)    
Accrued liabilities         (153,400) 486,362    
Development liability         (400,000)    
Net cash used in operating activities         (6,051,597) (4,990,704)    
Cash flows from financing activities:                
Proceeds from loan payable, related party         100,000    
Proceeds from issuance of note payable, net of issuance costs         10,590,000    
Gross proceeds from issuance of common stock         4,597,999    
Net cash provided by financing activities         10,590,000 4,697,999    
Net change in cash, cash equivalents and restricted cash         4,538,403 (292,705)    
Total cash, cash equivalents and restricted cash at beginning of period   6,662,008   308,096 6,662,008 308,096 $ 308,096 $ 308,096
Total cash, cash equivalents and restricted cash at end of period 11,200,411   15,391   11,200,411 15,391 6,662,008 11,200,411
Beginning of period:                
Cash and cash equivalents   6,662,008   308,096 6,662,008 308,096 308,096 308,096
Restricted cash    
End of period:                
Cash and cash equivalents 8,188,140   15,391   8,188,140 15,391 6,662,008 8,188,140
Restricted cash $ 3,012,271     3,012,271 $ 3,012,271
Supplemental disclosure of cash flow information:                
Cash paid for interest            
Cash paid for taxes            
Supplemental disclosure of non-cash investing and financing activities:                
Conversion of note payable into common stock         411,000    
Equity line of commitment shares issued as offering costs         1,526,318    
Issuance of note receivable in exchange for other receivables         5,000,000    
Original issue discount and transaction expenses withheld from note payable principal         $ 420,000